Glenn Dubin's Net Worth

$15.3 Million

Estimate Recalculated Jul 11, 2024 03:18PM EST

Who is Glenn Dubin?

Glenn Dubin has an estimated net worth of $15.3 Million. This is based on reported shares across multiple companies, which include ENZON PHARMACEUTICALS INC, Golden Minerals Co, XCYTE THERAPIES INC, AMBASSADORS INTERNATIONAL INC, DOV PHARMACEUTICAL INC, OSCIENT PHARMACEUTICALS CORP, ASGI Corbin Multi-Strategy Fund, LLC, and C4 Therapeutics, Inc..

SEC CIK

Glenn Dubin's CIK is 0001308597

Past Insider Trading and Trends

2007 was Glenn Dubin's most active year for acquiring shares with 29 total transactions. Glenn Dubin's most active month to acquire stocks was the month of March. 2007 was Glenn Dubin's most active year for disposing of shares, totalling 29 transactions. Glenn Dubin's most active month to dispose stocks was the month of March. 2007 saw Glenn Dubin paying a total of $4,175,527.83 for 13,835,481 shares, this is the most they've acquired in one year. In 2011 Glenn Dubin cashed out on 497,151 shares for a total of $7,544,843.91, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ASGI Corbin Multi-Strategy Fund, LLC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-20.79K
$102.67
-$2,133,995.95
0
Jun 30
Form 4
-54.57%
-24.54K
$101.18
-$2,483,159.56
20.43K
Mar 30
Form 4
-58.68%
-63.59K
$99.63
-$6,334,973.55
44.77K
Dec 31
Form 3
—
0
—
—
0
No matching records found

C4 Therapeutics, Inc. (CCCC) Snapshot price: $5.51

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.56%
1.36K
$8.10
$10,999.80
22.07K
Apr 1
Form 4
+8.86%
1.69K
$6.52
$10,999.24
20.72K
Jan 2
Form 4
+51.51%
6.47K
$1.70
$10,999.00
19.03K
Oct 2
Form 4
+44.82%
3.89K
$2.83
$11,000.21
12.56K
Jul 3
Form 4
—
0
—
—
0
Jun 15
Form 4
+65.67%
3.44K
$3.20
$11,001.60
8.67K
Apr 3
Form 4
+49.15%
1.73K
$6.38
$11,005.50
5.24K
Jan 3
Form 4
+56.35%
1.26K
$8.69
$10,992.85
3.51K
Oct 3
Form 4
+157.16%
1.37K
$8.03
$11,017.16
2.25K
Jul 1
Form 4
—
0
—
—
0
Jun 22
Form 4
+76.72%
379
$26.46
$10,028.34
873
Apr 4
Form 4
+67.46%
199
$31.58
$6,284.42
494
Jan 4
Form 4
+87.90%
138
$44.99
$6,208.62
295
Oct 4
Form 4
∞
157
$39.72
$6,236.04
157
Jul 2
Form 4
—
0
—
—
0
Mar 12
Form 3
—
0
—
—
0
No matching records found

ENZON PHARMACEUTICALS INC (ENZN) Snapshot price: $0.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 11
Form 4
—
0
$6.49
—
2.34K
Aug 13
Form 4
—
0
$7.21
—
60K
Aug 2
Form 4
—
0
$7.71
—
55K
Jul 24
Form 4
—
0
$7.75
—
22.19K
Jul 16
Form 4
—
0
$7.73
—
54.01K
Jul 11 - Jul 12
Form 4
—
0
$8.25
—
10.25K
Apr 10 - Apr 11
Form 4
—
0
$8.24
—
11.3K
Apr 9
Form 4
—
0
$8.32
-$20,000.00
700
Mar 2
Form 4
—
0
$8.72
-$2,700.00
30K
Feb 15
Form 3
—
0
—
—
0
No matching records found

Golden Minerals Co (AUMN) Snapshot price: $0.4379

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-88.53%
-347.77K
$8.50
-$2,956,011.00
45.08K
Mar 19
Form 4
+0.41%
1.6K
—
—
392.84K
Mar 24
Form 3
—
0
—
—
0
No matching records found

XCYTE THERAPIES INC (CYCC) Snapshot price: $2.3718

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3/A
—
0
—
—
0
No matching records found